Diversity, Equity & Inclusion at Parexel

Parexel celebrates the diversity of its workforce and patients and ensures an inclusive environment across gender, gender identity, race and ethnicity, sexual orientation, disability, age or other differences. We foster a culture where our colleagues, customers and patients can give their best contribution and agree that “this is the place for me.”

"Our jobs, our fundamental work in clinical research, is impacted by having diverse clinical trials. And it’s hard to actually do that if you don’t reflect it as a company."
Quote by Peyton Howell, Chief Operating and Growth Officer, from the below video where our Executive Leadership Team share about DEI at Parexel.

We drive inclusion through a strategic three-pillar strategy of Patients, People and Suppliers supported by an Executive Committee.

Supporting our “Patients First” core value, Parexel is dedicated to being the patient-led CRO, ensuring that patient inclusion becomes business as usual. The inclusion of a diverse patient population in clinical trials is essential for ensuring efficacy, safety, and equity for patients in the real world. We have a dedicated team who provides support, resources, and guidance to clients, sites, and project teams. We work together to help patients feel included in their healthcare journey.

Our People are supported through a robust diversity, equity and inclusion strategy with a vision that all are valued, respected and supported for who they are, no matter where they are around the world. This work is driven through five steering committees, nine regional committees, business unit committees and extensive leadership development training and programming.

Join one of our Employee Resource Groups:

Through our Supplier Diversity Program, we introduce a broad range of suppliers who bring forth varied perspectives, creativity and innovative ideas to our customers, partners and colleagues.